Long-term immune protection against HBV: associated factors and determinants

References

• Compulsory vaccination against hepatitis B virus. 1991 Jun 1. [accessed 2020 Jun 24]. http://old.iss.it/binary/tras/cont/19910527_LEGGE%2027%20maggio%201991%20vaccinazione.1181036033.pdf
   Google Scholar
• Piazza M, Da Villa G, Picciotto L, Abrescia N, Guadagnino V, Memoli AM. Mass vaccination against hepatitis B in infants in Italy. Lancet. 1988;332:1132. doi:10.1016/S0140-6736(88)90540-5.
   Google Scholar
• Mele A, Stroffolini T, Zanetti AR. Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination. J Med Virol. 2002;67:440–43. doi:10.1002/jmv.10092.
   PubMed Web of Science ®Google Scholar
• Schillie S, Murphy TV, Sawyer M, Ly K, Hughes E, Jiles R, de Perio MA, Relly M, Byrd K, Ward JW. CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recomm Rep. 2013;62:1–19.
   PubMed Web of Science ®Google Scholar
• Lamberti M, De Rosa A, Garzillo EM, Corvino AR, Sannolo N, De Pascalis S, Di Fiore E, Westermann C, Arnese A, Di Giuseppe G, et al. Vaccination against hepatitis b virus: are Italian medical students sufficiently protected after the public vaccination programme? J Occup Med Toxicol. 2015;10:41. doi:10.1186/s12995-015-0083-4.
   PubMed Web of Science ®Google Scholar
• Italian Law decree n. 81 of 9h April 2008. [accessed 2020 24 June]. http://www.lavoro.gov.it/documenti-e-norme/studi-estatistiche/Documents/Testo%20Unico%20sulla%20Salute%20e%20Sicurezza%20sul%20Lavoro/Testo-Unico-81-08-Edizione-Giugno%202016.pdf
   Google Scholar
• Italian Ministry of Health. National vaccination prevention plan 2014–2018. 2014 Nov 13. [accessed 2020 Jun 24]. http://www.salute.gov.it/imgs/C_17_pubblicazioni_2285_allegato.pdf
   Google Scholar
• Durando P, Crovari P, Ansaldi F, Sticchi L, Turello V, Marensi L, Giacchino R, Timitilli A, Carloni R, et al. Universal childhood immunisation against Streptococcus pneumoniae: the five-year experience of Liguria Region, Italy. Vaccine. 2009;27:3459–62. doi:10.1016/j.vaccine.2009.01.052.
   PubMed Web of Science ®Google Scholar
• Zanetti AR. Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study. Lancet Infect Dis. 2010;10:755–56. doi:10.1016/S1473-3099(10)70195-X.
   PubMed Web of Science ®Google Scholar
• Gabutti A, Romanò L, Blanc P, Meacci F, Amendola A, Mele A, Mazzotta F, Zanetti AR. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents. Vaccine. 2007;25:3129–32. doi:10.1016/j.vaccine.2007.01.045.
   PubMed Web of Science ®Google Scholar
• Zanetti AR, Mariano A, Romanò L, D’Amelio R, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, Negrone FS, et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet. 2005;366:1379–84. doi:10.1016/S0140-6736(05)67568-X.
   PubMed Web of Science ®Google Scholar
• Zaffina S, Marcellini V, Santoro AP, Scarsella M, Camisa V, Vinci MR, Musolino AM, Nicolosi L, Rosado MM, Carsetti R, et al. Repeated vaccinations do not improve specific immune defenses against Hepatitis B in non-responder healthcare workers. Vaccine. 2014;32:6902–10. doi:10.1016/j.vaccine.2014.10.066.
   PubMed Web of Science ®Google Scholar
• Batra V, Goswami A, Dadhich S, Kothari D, Bhargava N. Hepatitis B immunization in healthcare workers. Ann Gastroenterol. 2015;28:276–80.
   PubMed Web of Science ®Google Scholar
• Tajiri K, Shimizu Y. Unsolved problems and future perspectives of hepatitis B virus vaccination. World J Gastroenterol. 2015;21:7074–83. doi:10.3748/wjg.v21.i23.7074.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Viral Hepatitis Statistics and Surveillance. 2020 May 8. [accessed 2020 Jun 24]. http://www.cdc.gov/hepatitis/statistics/index.htm
   Google Scholar
• Riva MA, Madotto F, Conti S, Fornari C, Patronella G, Sormani M, Dorso MI, De Vito G, Latocca R, Cesana G. Hepatitis B vaccination coverage and booster dose: results from a survey on healthcare students. G Ital Med Lav Ergon. 2012;34:283–85.
   PubMedGoogle Scholar
• Spradling PR, Williams RE, Xing J, Soyemi K, Towers J. Serologic testing for protection against hepatitis B virus infection among students at a health sciences university in the United States. Infect Control Hosp Epidemiol. 2012;33:732–36. doi:10.1086/666335.
   PubMed Web of Science ®Google Scholar
• Bruno A, Borella-Venturini M, Giraldo M, Mongillo M, Zanetti E, Beggio M, Davanzo E, Trevisan A. Prevalence of virus hepatitis B markers among medical students. G Ital Med Lav Ergon. 2007;29:752–54.
   PubMedGoogle Scholar
• Repubblica Italiana, Ministero della Salute. Protocollo per l’esecuzione della vaccinazione contro l’epatite virale B (D.M. 20 novembre 2000). 2020 Nov 30. [accessed 2020 Jun 24]. http://www.salute.gov.it/imgs/C_17_normativa_1517_allegato.pdf
   Google Scholar
• Venters C, Graham W, Cassidy W. Recombivax-HB: perspectives past, present and future. Expert Rev Vaccines. 2004;3(2):119–29. doi:10.1586/14760584.3.2.119.
   PubMedGoogle Scholar
• Kang G, Chen H, Ma F, Yang Y, Wang Z, Guo S, Song J. Comparison of the effect of increased hepatitis B vaccine dosage on immunogenicity in healthy children and adults. Hum Vaccin Immunother. 2016;12(9):2312–16. doi:10.1080/21645515.2016.1172757.
   PubMed Web of Science ®Google Scholar
• Li J, Yao J, Shan H, Chen Y, Jiang ZG, Ren JJ, Xu KJ, Ruan B, Yang SG, Wang B, et al. Comparison of the effect of two different doses of recombinant hepatitis B vaccine on immunogenicity in healthy adults. Hum Vaccin Immunother. 2015;11:1108–13. PMID:25607773.
   PubMed Web of Science ®Google Scholar
• Lin CS, Xie SB, Liu J, Zhao ZX, Chong YT, Gao ZL. Effect of revaccination using different schemes among adults with low or undetectable anti-HBs titers after hepatitis B virus vaccination. Clin Vaccine Immunol. 2010;17:1548–516. PMID:20719983. doi:10.1128/CVI.00064-10.
   PubMedGoogle Scholar
• Gilbert CL, Klopfer SO, Martin JC, Schodel FP, Bhuyan PK. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults >/=50 years. Hum Vaccin. 2011;7:1336–42. doi:10.4161/hv.7.12.18333.
   PubMed Web of Science ®Google Scholar
• Saso A, Kampmann B. Vaccine responses in newborns. Semin Immunopathol. 2017;39(6):627–42. doi:10.1007/s00281-017-0654-9.
   PubMed Web of Science ®Google Scholar
• Hong M, Bertoletti A. Tolerance and immunity to pathogens in early life: insights from HBV infection. Semin Immunopathol. 2017;39(6):643–52. doi:10.1007/s00281-017-0641-1.
   PubMed Web of Science ®Google Scholar
• Faustini A, Franco E, Sangalli M, Spadea T, Calabrese RM, Cauletti M, Perucci CA. Persistence of anti-HBs 5 years after the introduction of routine infant and adolescent vaccination in Italy. Vaccine. 2001;19:2812–18. doi:10.1016/S0264-410X(01)00005-6.
   PubMed Web of Science ®Google Scholar
• Chiara F, Bartolucci GB, Mongillo M, Ferretto L, Nicolli A, Trevisan A. Hepatitis B vaccination at three months of age: a successful strategy? Vaccine. 2013;31:1696–700. doi:10.1016/j.vaccine.2013.01.046.
   PubMed Web of Science ®Google Scholar
• Stroffolini T, Guadagnino V, Caroleo B, De Sarro G, Focà A, Liberto MC, Giancotti A, Barreca GS, Marascio N, Lombardo FA, et al. Long-term immunogenicity of hepatitis B vaccination in children and adolescents in a southern Italian town. Infection. 2012;40:299–302. doi:10.1007/s15010-011-0233-2.
   PubMed Web of Science ®Google Scholar
• Verso MG, Lo Cascio N, Noto Laddeca E, Amodio E, Currieri M, Giammanco G, Ferraro D, De Grazia S, Picciotto D. Predictors of Hepatitis B Surface Antigen Titers two decades after vaccination in a cohort of students and post-graduates of the Medical School at the University of Palermo, Italy. Ann Agric Environ Med. 2017;24:303‐306. doi:10.26444/aaem/74716.
   PubMed Web of Science ®Google Scholar